Pfizer Pulls Plug On Weight Loss Pill Amid Liver Damage Fears
Favicon 
www.oann.com

Pfizer Pulls Plug On Weight Loss Pill Amid Liver Damage Fears

Pfizer announced it is ending its development of its experimental oral GLP-1 drug to treat obesity, the company said on Monday, after a patient in a trial suffered a liver injury potentially caused by the experimental drug known as danuglipron.